A SUSTAINABLE SURGICAL SOLUTION

THE SCIENCE OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE AIMS TO PROVIDE SURGEONS WITH A SUSTAINABLE SOLUTION TO PATIENTS UNDERGOING RECONSTRUCTIVE SURGERY.

Get Started
Our History

Our History

About 3D Plasty

3D Plastyspecialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. 3D Plasty's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry.

The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the 3D Plastyproducts provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. 3D Plastyproducts are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.

History of Development

3D Plasty platform technology started development in 1996, acquiring extensive engineering and clinical experience.

US FDA GMP Inspection - Feb 2019

Successful inspection by US FDA inspector at our JTC MedTech Hub manufacturing facility

3D Plasty Manufacturing Process - 2018

Upgraded to ISO 13485 Medical Device Regulation

3D Plasty Manufacturing Process - 2016

Achieved the Korea GMP in 2016

CE Mark Approval - 2009

CE Mark Approval for Osteoplugâ„¢ for burr hole cover, and Osteomeshâ„¢ for orbital floor reconstruction

3D Plasty Manufacturing Process - 2007

Achieved the ISO 13485 certification